Gland Pharma Ltd.
Snapshot View

2658.60 +14.90 ▲0.6%

27 June 2022, 04:01:00 PM
Volume: 10,517

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glandpharma.com
Market Cap 43,775.42 Cr.
Enterprise Value(EV) 40,685.92 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 73.59 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 36.13 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 434.70 Trailing Twelve Months Ending 2022-03
Price to Book Value 6.12 Calculated using Price: 2,658.60
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 16.47 Cr. 164,655,923 Shares
FaceValue 1
Company Profile
The company was incorporated as Gland Pharma Private Limited, a private limited company, at Hyderabad under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of the company was changed to Gland Pharma Limited pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994, and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad consequent upon change of name and conversion into a public limited company under the Companies Act, 1956.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.56%
1 Week
+2.99%
1 Month
-8.54%
3 Month
-16.94%
6 Month
-31.55%
1 Year
-16.73%
2 Year
5 Year
10 Year
2 years 2020-03 2021-03
Return on Equity (%) 21.29 20.97
Return on Capital Employed (%) 27.39 28.00
Return on Assets (%) 18.91 18.84

Balance Sheet View Details

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 3,646 5,903 7,158
Non Curr. Liab. 81 80 94
Curr. Liab. 359 513 582
Minority Int.
Equity & Liab. 4,086 6,496 7,834
Non Curr. Assets 1,240 1,372 1,982
Curr. Assets 2,846 5,124 5,852
Misc. Exp. not W/O
Total Assets 4,086 6,496 7,834

Profit Loss View Details

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 2,633 3,463 4,401
Other Income 139 135 224
Total Income 2,772 3,598 4,625
Total Expenditure -1,678 -2,161 -2,891
PBIDT 1,095 1,437 1,734
Interest -7 -3 -5
Depreciation -95 -99 -110
Taxation -220 -338 -407
Exceptional Items
PAT 773 997 1,212
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 773 997 1,212
Adjusted EPS 50 61 74

Cash Flow View Details

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 701 605
Cash Fr. Inv. -766 -1,524
Cash Fr. Finan. -7 1,238
Net Change -72 319
Cash & Cash Eqvt 170 492

Shareholding Pattern View Details

9 Qtrs 2016-09 (%) 2017-09 (%) 2018-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 41.61 41.92 96.08 58.36 58.25 58.14 58.02 58.00 58.00
Public 58.39 58.08 3.92 41.64 41.75 41.86 41.98 42.00 42.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 27 Jun 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor meetings
Fri, 17 Jun 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor meetings
Wed, 15 Jun 2022
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 79 400 Equity shares under ESOP

Technical Scans View Details

Mon, 27 Jun 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Piramal Enterprises Ltd. 39,749.44 1,665.10 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2022-03 20.64 1,665.10 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2022-03 1.12 1,665.10 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 1,665.10 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 1,665.10 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 1,665.10 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 1,665.10 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 1,665.10 +0.8%

FAQ's On Gland Pharma Ltd.

Can I Buy Gland Pharma Shares now?

What is the Share Price of Gland Pharma?

What is the Relative Strength Index (RSI) Value of Gland Pharma?

What is the Market Capital (MCAP) of Gland Pharma?

What are the key metrics to analyse Gland Pharma?

What is the Price Performance of Gland Pharma?